UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

May 23, 2019

( Date of Report, Date of Earliest Event Reported )

 

COVIA HOLDINGS CORPORATION

( Exact Name of Registrant as Specified in Charter )

 

001-38510

( Commission File Number )

 

Delaware

 

13-2656671

( State or Other Jurisdiction of Incorporation or Organization )

 

( I.R.S. Employer Identification No. )

 

 

 

3 Summit Park Drive, Suite 700, Independence, Ohio

 

44131

(Address of Principal Executive Offices)

 

(Zip Code)

 

(800) 255-7263

( Registrant’s Telephone Number, Including Area Code )

Not Applicable

( Former Name or Former Address, if Changed Since Last Report )

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting mater ial pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Securities registered pursuant to Section 12(b) of the Act :

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock

CVIA

New York Stock Exchange

 

 

 

 


 

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 23, 2019, the Board of Directors (“Board”) of Covia Holdings Corporation (“we,” “us,” “our” or “registrant”) approved the Covia Executive Severance Plan (“Plan”).  The Plan covers our employees at or above the vice president level, including our named executive officers.  The Plan provides severance payments and benefits to eligible employees who are terminated from employment without Cause or on account of a Constructive Termination, as each term is defined in the Plan.

The benefits provided under the Plan equal (i) a severance payment calculated using a factor determined by the participant’s level and multiplying the factor by the sum of the participant’s base salary and target short-term bonus opportunity, and (ii) if the qualifying termination occurs after September 1, the prorated portion of the short-term bonus that is actually earned for the year in which the termination occurs.  If the qualifying termination occurs during a Change in Control Period, as defined in the Plan, the benefits provided under the Plan equal (i) a severance payment calculated using a factor determined by the participant’s level and multiplying the factor by the sum of the participant’s base salary and target short-term bonus opportunity, and (ii) the prorated portion of the participant’s target short-term bonus opportunity. In each case, the participant will also receive outplacement assistance and subsidized health coverage.  The factor used for determining the severance payment is 1.5 for our named executive officers at the executive vice president level (2.0 if during a Change in Control Period) and 2.0 for our chief executive officer (2.99 if during a Change in Control Period).  If a participant dies or terminates employment on account of a disability, the participant will be entitled to the prorated short-term bonus that is actually earned for the year in which such termination occurs, but termination on account of death or disability will not trigger other benefits under the Plan.

The Plan provides restrictive covenants in our favor, including confidentiality, non-competition, non-solicitation and non-disparagement, and a post-termination cooperation covenant.  The length of the period for the covenants is 1.5 years for our named executive officers at the executive vice president level and 2 years for our chief executive officer.  In the event a participant is entitled to benefits under the Plan and any other plan, policy or agreement with us (including those plans, policies and agreements with Fairmount Santrol Holdings Inc. or Unimin Corporation), the participant will be eligible to receive the greater of the aggregate benefits payable under the Plan or the aggregate benefits payable under such other plan, policy or agreement, with no duplication of benefits.  

A copy of the Plan is filed as Exhibit 10.1 to this Form 8-K.  The foregoing description of the Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the Plan which is incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holder s.

On May 23, 2019, we held our annual meeting of stockholders (“Annual Meeting”).  At the Annual Meeting, our stockholders voted on four matters, with the results of the voting as follows:

Item 1 – Election of Directors .  To elect as directors the nominees named in our April 12, 2019 proxy statement (“Proxy Statement”).  As noted in our Current Report on Form 8-K filed on May 9, 2019, Jenniffer D. Deckard resigned as our President and Chief Executive Officer and as a member of our Board of Directors (“Board”), effective on May 7, 2019.   In connection with Ms. Deckard’s resignation, the size of the Board was reduced from 13 directors to 12 directors.  As a result, the Board presented at the Annual Meeting only the remaining 12 Board nominees for election, and the votes received by Ms. Deckard were disregarded.

Nominee

For

Against

Abstain

Broker Non-Vote

William E. Conway

97,737,498

348,936

106,928

18,062,724

Kurt Decat

91,212,412

6,780,750

200,200

18,062,724

Jean-Luc Deleersnyder

91,207,377

6,785,523

200,462

18,062,724

Michel Delloye

97,220,184

771,335

201,843

18,062,724

Charles D. Fowler

97,410,265

673,783

109,314

18,062,724

Jean-Pierre Labroue

97,141,061

851,725

200,576

18,062,724

 


 

Olivier Lambrechts

91,223,295

6,763,577

206,490

18,062,724

Matthew F. LeBaron

97,726,258

327,914

139,190

18,062,724

William P. Kelly

97,765,660

291,831

135,871

18,062,724

Stephen J. Hadden

97,724,714

299,354

169,294

18,062,724

Richard A. Navarre

91,484,802

6,569,342

139,218

18,062,724

Jeffrey B. Scofield

97,271,882

758,845

162,635

18,062,724

Jenniffer D. Deckard

2,702,242

528,782

94,962,338

18,062,724

Item 2 – Say-on-Pay Vote .  To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.

For

Against

Abstain

Broker Non-Vote

95,907,680

2,232,499

53,183

18,062,724

Item 3 – Say-on-Frequency Vote .  To vote, on an advisory basis, on the frequency of future advisory votes on the compensation of our named executive officers.

1-Year

2-Years

3-Years

Abstain

97,967,464

35,866

136,150

53,882

Item 4 – Ratification of the Appointment of Ernst & Young LLP .  To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2019.

For

Against

Abstain

115,957,845

189,732

108,509

No other matters were submitted to a vote of our stockholders at the Annual Meeting.

Item 9.01 Financial Statements and Exhibits

 

(d)

Exhibits.   Exhibits denoted with an asterisk (*) are filed herewith.

 

 

Exhibit No.

Description

 

10.1*†

Covia Executive Severance Plan effective May 23, 2019 .

_________________________________

 

Management contract or compensatory plan, contract or arrangement.

 


 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

 

COVIA HOLDINGS CORPORATION

 

 

 

 

Date:

May 29, 2019

/s/ Andrew D. Eich

 

Andrew D. Eich

 

Executive Vice President and Chief Financial Officer

 

 

 

Covia (NYSE:CVIA)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Covia Charts.
Covia (NYSE:CVIA)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Covia Charts.